PortfoliosLab logoPortfoliosLab logo
IBD vs. USL
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IBD vs. USL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Inspire Corporate Bond Impact ETF (IBD) and United States 12 Month Oil Fund LP (USL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IBD achieves a -0.18% return, which is significantly lower than USL's 63.07% return.


IBD

1D
-0.19%
1M
-0.01%
YTD
-0.18%
6M
0.16%
1Y
4.61%
3Y*
5.01%
5Y*
1.30%
10Y*

USL

1D
1.55%
1M
-1.61%
YTD
63.07%
6M
59.66%
1Y
57.86%
3Y*
18.42%
5Y*
17.41%
10Y*
10.91%
*Multi-year figures are annualized to reflect compound growth (CAGR)

IBD vs. USL - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
IBD
Inspire Corporate Bond Impact ETF
-0.18%7.70%3.58%6.00%-8.94%-1.89%5.15%7.97%-1.18%1.32%
USL
United States 12 Month Oil Fund LP
63.07%-12.37%8.30%-1.11%27.10%62.48%-25.23%28.01%-14.15%27.41%

Correlation

The correlation between IBD and USL is -0.26, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.26

Correlation (3Y)
Calculated over the trailing 3-year period

-0.07

Correlation (5Y)
Calculated over the trailing 5-year period

-0.06

Correlation (All Time)
Calculated using the full available price history since Jul 12, 2017

-0.03

Over the past year, the inverse relationship between IBD and USL has strengthened: their correlation has moved from -0.03 to -0.26, meaning they now move in opposite directions more often than their long-term average.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IBD vs. USL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IBD
IBD Risk / Return Rank: 3535
Overall Rank
IBD Sharpe Ratio Rank: 3030
Sharpe Ratio Rank
IBD Sortino Ratio Rank: 3131
Sortino Ratio Rank
IBD Omega Ratio Rank: 2828
Omega Ratio Rank
IBD Calmar Ratio Rank: 4444
Calmar Ratio Rank
IBD Martin Ratio Rank: 4141
Martin Ratio Rank

USL
USL Risk / Return Rank: 5656
Overall Rank
USL Sharpe Ratio Rank: 5959
Sharpe Ratio Rank
USL Sortino Ratio Rank: 5353
Sortino Ratio Rank
USL Omega Ratio Rank: 5454
Omega Ratio Rank
USL Calmar Ratio Rank: 6969
Calmar Ratio Rank
USL Martin Ratio Rank: 4343
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IBD vs. USL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Inspire Corporate Bond Impact ETF (IBD) and United States 12 Month Oil Fund LP (USL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


IBDUSLDifference
Sharpe ratioReturn per unit of total volatility

-0.94

Sortino ratioReturn per unit of downside risk

-0.91

Omega ratioGain probability vs. loss probability

1.19

1.34

-0.15

Calmar ratioReturn relative to maximum drawdown

2.15

3.47

-1.32

Martin ratioReturn relative to average drawdown

6.66

7.02

-0.36

IBD vs. USL - Sharpe Ratio Comparison

The current IBD Sharpe Ratio is 1.10, which is lower than the USL Sharpe Ratio of 2.04. The chart below compares the historical Sharpe Ratios of IBD and USL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


IBDUSLDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.10

2.04

-0.94

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.23

0.58

-0.35

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.34

Sharpe Ratio (All Time)

Calculated using the full available price history

0.31

0.01

+0.30

Drawdowns

IBD vs. USL - Drawdown Comparison

The maximum IBD drawdown since its inception was -16.30%, smaller than the maximum USL drawdown of -89.06%. Use the drawdown chart below to compare losses from any high point for IBD and USL.


Loading charts...

Drawdown Indicators


IBDUSLDifference

Max Drawdown

Largest peak-to-trough decline

-16.30%

-89.06%

+72.76%

Max Drawdown (1Y)

Largest decline over 1 year

-2.15%

-16.76%

+14.61%

Max Drawdown (3Y)

Largest decline over 3 years

-4.01%

-23.33%

+19.32%

Max Drawdown (5Y)

Largest decline over 5 years

-14.76%

-33.82%

+19.06%

Max Drawdown (10Y)

Largest decline over 10 years

-66.02%

Current Drawdown

Current decline from peak

-1.04%

-38.16%

+37.12%

Average Drawdown

Average peak-to-trough decline

-3.36%

-61.46%

+58.10%

Ulcer Index

Depth and duration of drawdowns from previous peaks

0.69%

8.27%

-7.58%

Volatility

IBD vs. USL - Volatility Comparison

The current volatility for Inspire Corporate Bond Impact ETF (IBD) is 1.03%, while United States 12 Month Oil Fund LP (USL) has a volatility of 10.53%. This indicates that IBD experiences smaller price fluctuations and is considered to be less risky than USL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IBDUSLDifference

Volatility (1M)

Calculated over the trailing 1-month period

1.03%

10.53%

-9.50%

Volatility (6M)

Calculated over the trailing 6-month period

2.83%

23.33%

-20.50%

Volatility (1Y)

Calculated over the trailing 1-year period

4.21%

28.54%

-24.33%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

5.60%

30.08%

-24.48%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

6.70%

32.35%

-25.65%

IBD vs. USL - Expense Ratio Comparison

IBD has a 0.49% expense ratio, which is lower than USL's 0.88% expense ratio.


Dividends

IBD vs. USL - Dividend Comparison

IBD's dividend yield for the trailing twelve months is around 4.25%, while USL has not paid dividends to shareholders.


PositionTTM202520242023202220212020201920182017
IBD
Inspire Corporate Bond Impact ETF
4.25%4.17%4.18%3.39%1.75%1.36%1.63%2.47%2.06%0.82%
USL
United States 12 Month Oil Fund LP
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


IBD and USL have a correlation of -0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

USL has higher volatility (10.53%) compared to IBD (1.03%). In terms of maximum drawdown, IBD dropped -16.30% vs USL's -89.06%.

On 5-year performance, USL leads with 17.41% vs 1.30% for IBD. On fees, IBD is cheaper at 0.49% per year. On volatility, IBD has been the lower-risk option at 1.03%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, USL has performed better with a 17.41% return vs 1.30%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

IBD is cheaper with a 0.49% expense ratio, compared with 0.88% for USL.

IBD has the higher dividend yield at 4.25%, compared with 0.00% for USL.

IBD is categorized as Corporate Bonds, while USL is Oil & Gas. IBD tracks Inspire Corporate Bond Impact Equal Weight Index, while USL tracks 12 Month Light Sweet Crude Oil. They also come from different issuers: Inspire and Concierge Technologies. Their fees differ too: 0.49% for IBD and 0.88% for USL.

USL currently has the higher Sharpe Ratio (2.04 vs 1.10), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IBD and USL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer